E-LIB Suche - Ergebnisse für: González-Larriba, J. L.

1

138P Faecalibacterium prausnitzii enhances tumor response t..:

Rodriguez-Festa, A. ; Serna-Blasco, R. ; Nadal, E....
ESMO Open. 9 (2024) - p. 102725 , 2024

Link: https://doi.org/10.1016/..

2

MA16.04 Circulating Tumor DNA Quantification by NGS Should ..:

Serna Blasco, R. ; Nadal, E. ; Calvo, V....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S157-S158 , 2023

Link: https://doi.org/10.1016/..

3

P1.21-07 Quantitative Assessment of OX40L and Its Associati..:

Baena, J. ; Calles, A. ; Aguado, C....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S236-S237 , 2023

Link: https://doi.org/10.1016/..

4

EP08.03-01 Copy Number Variants and Late Somatic Mutations ..:

Serna Blasco, R. ; García Campelo, M.R. ; Nadal, E....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S588 , 2023

Link: https://doi.org/10.1016/..

5

P1.27-07 BRAF Mutations Identify Non-small-Cell Lung Cancer..:

Robado de Lope, L. ; Nadal, E. ; Calvo, V....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S286 , 2023

Link: https://doi.org/10.1016/..

6

13MO Safety and efficacy of tusamitamab ravtansine in combi..:

Isambert, N. ; Nagy, T. ; Ravoire, M....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S46-S47 , 2023

Link: https://doi.org/10.1016/..

7

P1.09-03 Multidisciplinary Thoracic Tumors Board Survey in ..:

Massutí, B. ; Nadal, E. ; Camps, C....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S107 , 2022

Link: https://doi.org/10.1016/..

8

SEOM-GECP-GETTHI Clinical Guidelines for the treatment of p..:

Remon, J. ; Bernabé, R. ; Diz, P....
Clinical and Translational Oncology. 24 (2022) 4 - p. 635-645 , 2022

Link: https://doi.org/10.1007/..

9

Malignant pleural mesothelioma: Treatment patterns and outc..:

Remon, J. ; Nadal, E. ; Dómine, M....
Lung Cancer. 147 (2020) - p. 83-90 , 2020

Link: https://doi.org/10.1016/..

10

PO-412 Effectiveness and safety of anti-PD1 (Nivolumab) as ..:

Fusco, J.P. ; Acosta, D. ; Pérez-Carrión, R....
ESMO Open. 3 (2018) - p. A391 , 2018

Link: https://doi.org/10.1136/..

11

Long-term survival in advanced non-squamous NSCLC patients ..:

De Castro, J. ; González-Larriba, J. L. ; Vázquez, S....
Clinical and Translational Oncology. 19 (2016) 2 - p. 219-226 , 2016

Link: https://doi.org/10.1007/..

12

Resistance to Targeted Therapies in Renal Cancer: The Impor..:

Duran, I. ; Lambea, J. ; Maroto, P....
Targeted Oncology. 12 (2016) 1 - p. 19-35 , 2016

Link: https://doi.org/10.1007/..

13

2638 Effectiveness of 2nd-line and subsequent therapies aft..:

Arija, J.A. Arranz ; Pérez-Valderrama, B. ; González-Larriba, J.L....
European Journal of Cancer. 51 (2015) - p. S526 , 2015

Link: https://doi.org/10.1016/..

14

A 50-gene signature is a novel scoring system for tumor-inf..:

Hernández-Prieto, S. ; Romera, A. ; Ferrer, M....
Clinical and Translational Oncology. 17 (2014) 4 - p. 330-338 , 2014

Link: https://doi.org/10.1007/..

15

Cost-Utility Analysis of Pazopanib Verse Sunitinib as First..:

Espinosa, J. ; González-Larriba, J,L. ; Maroto, P...
Value in Health. 17 (2014) 7 - p. A632-A633 , 2014

Link: https://doi.org/10.1016/..